TE_116
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | Ricksha_c, MLT2A1 |
|---|---|
| TE superfamily | ERV3, MuDR |
| TE class | DNA, LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 1.58 |
| Counts of samples | TCGA_tumor:160; TCGA_normal:19; GTEx:95 |
| TSS | chr1(-):12389158 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_116.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):12357384,12357404,12376071,12376169,12389011,12389159 |
| teRNA_116.2 | - | Intergenic | Other | MLSALEHWTPSSSVLGLGLVLLAPQLADSLLWELVIINRKHLCTAPETTGKASRLSCRCCRLGINTDIPRRRMRLGWLHMPRGWLHPLQYPELSSILFPCLKR* | chr1(-):12356951,12356971,12357306,12357404,12376071,12376169,12389011,12389159 |
| teRNA_116.3 | - | Intergenic | Non-coding | Non-coding | chr1(-):12361084,12361104,12376071,12376169,12389011,12389159 |
| teRNA_116.4 | - | Intergenic | Other | MLSALEHWTPSSSVLGLGLVLLAPQLADSLLWELVIINRKHLCTAPETTGKASRLSCRCCRLGINTDIPRRRMRLGWLHMPRGWLHPLQYPELSSILFPCLKR* | chr1(-):12356951,12356971,12357199,12357404,12376071,12376169,12389011,12389159 |
| teRNA_116.5 | - | Intergenic | Non-coding | Non-coding | chr1(-):12342034,12342054,12357199,12357404,12376071,12376169,12389011,12389159 |
| teRNA_116.6 | - | Intergenic | Non-coding | Non-coding | chr1(-):12342995,12343015,12357199,12357404,12376071,12376169,12389011,12389159 |
| teRNA_116.7 | - | Intergenic | Non-coding | Non-coding | chr1(-):12363924,12363944,12376071,12376169,12389011,12389159 |
| teRNA_116.8 | - | Intergenic | Non-coding | Non-coding | chr1(-):12378120,12378140,12385117,12385331,12389011,12389159 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
